Pages that link to "Q36071638"
Jump to navigation
Jump to search
The following pages link to Current progress of siRNA/shRNA therapeutics in clinical trials (Q36071638):
Displaying 50 items.
- Novel Molecular Markers for Breast Cancer (Q26753160) (← links)
- Keeping abreast with long non-coding RNAs in mammary gland development and breast cancer (Q26849813) (← links)
- Non-coding RNAs in lung cancer (Q26866521) (← links)
- RNA interference and its role in cancer therapy (Q27010649) (← links)
- Current translational and clinical practices in hematopoietic cell and gene therapy (Q27024456) (← links)
- ZikaVR: An Integrated Zika Virus Resource for Genomics, Proteomics, Phylogenetic and Therapeutic Analysis (Q27468686) (← links)
- Delivery of RNAi Therapeutics to the Airways-From Bench to Bedside (Q28067306) (← links)
- Disrupting P-glycoprotein function in clinical settings: what can we learn from the fundamental aspects of this transporter? (Q28069761) (← links)
- NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer? (Q28078448) (← links)
- Preclinical and clinical development of siRNA-based therapeutics (Q28085290) (← links)
- Progress toward in vivo use of siRNAs-II (Q28255877) (← links)
- Nuclear multidrug-resistance related protein 1 contributes to multidrug-resistance of mucoepidermoid carcinoma mainly via regulating multidrug-resistance protein 1: a human mucoepidermoid carcinoma cells model and Spearman's rank correlation analysis (Q28535696) (← links)
- Acoustic Cavitation-Mediated Delivery of Small Interfering Ribonucleic Acids with Phase-Shift Nano-Emulsions (Q30378008) (← links)
- Inhibition of CD44 gene expression in human skin models, using self-delivery short interfering RNA administered by dissolvable microneedle arrays (Q30524055) (← links)
- Silencing herpes simplex virus type 1 capsid protein encoding genes by siRNA: a promising antiviral therapeutic approach (Q33560548) (← links)
- siRNA delivery targeting to the lung via agglutination-induced accumulation and clearance of cationic tetraamino fullerene (Q33595545) (← links)
- Nanometer-scale siRNA carriers incorporating peptidomimetic oligomers: physical characterization and biological activity (Q33633338) (← links)
- Silencing of Jagged1 inhibits cell growth and invasion in colorectal cancer (Q33654212) (← links)
- Poly(amidoamine) dendrimer nanocarriers and their aerosol formulations for siRNA delivery to the lung epithelium (Q33732559) (← links)
- Hybrid lipid-polymer nanoparticles for sustained siRNA delivery and gene silencing (Q33831440) (← links)
- In vivo targeted delivery of CD40 shRNA to mouse intestinal dendritic cells by oral administration of recombinant Sacchromyces cerevisiae (Q33863257) (← links)
- Combination of BCL11A siRNA with vincristine increases the apoptosis of SUDHL6 cells (Q33864314) (← links)
- Cationic amphiphilic macromolecule (CAM)-lipid complexes for efficient siRNA gene silencing (Q33875414) (← links)
- Hydrolytic charge-reversal of PEGylated polyplexes enhances intracellular un-packaging and activity of siRNA (Q33918054) (← links)
- Targeting β-secretase with RNAi in neural stem cells for Alzheimer's disease therapy (Q34153594) (← links)
- Lipid-like nanomaterials for simultaneous gene expression and silencing in vivo. (Q34160892) (← links)
- Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab. (Q34205052) (← links)
- Advances with RNA interference in Alzheimer's disease research. (Q34330911) (← links)
- Silencing HoxA1 by intraductal injection of siRNA lipidoid nanoparticles prevents mammary tumor progression in mice (Q34395225) (← links)
- Enhanced breast cancer therapy with nsPEFs and low concentrations of gemcitabine (Q34402129) (← links)
- Non-viral vectors for gene-based therapy (Q34429032) (← links)
- Allele-specific gene silencing in two mouse models of autosomal dominant skeletal myopathy (Q34478102) (← links)
- Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4. (Q34479551) (← links)
- siRNAmod: A database of experimentally validated chemically modified siRNAs (Q34511095) (← links)
- Small interfering RNA-based molecular therapy of cancers (Q34552948) (← links)
- Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances (Q34622662) (← links)
- Synergistic effect of afatinib with su11274 in non-small cell lung cancer cells resistant to gefitinib or erlotinib (Q34635475) (← links)
- Pea3 expression promotes the invasive and metastatic potential of colorectal carcinoma. (Q34696571) (← links)
- Potent inhibition of Hendra virus infection via RNA interference and poly I:C immune activation (Q34731475) (← links)
- Small-molecule inhibitors of p21 as novel therapeutics for chemotherapy-resistant kidney cancer (Q34756265) (← links)
- Antisense Modulation of RNA Processing as a Therapeutic Approach in Cancer Therapy (Q34911031) (← links)
- A rationally designed nanoparticle for RNA interference therapy in B-lineage lymphoid malignancies (Q34939490) (← links)
- Screening nylon-3 polymers, a new class of cationic amphiphiles, for siRNA delivery. (Q35057561) (← links)
- siRNA suppression of hTERT using activatable cell-penetrating peptides in hepatoma cells (Q35207239) (← links)
- Deoxyribozymes: new therapeutics to treat central nervous system disorders (Q35228538) (← links)
- Innovative delivery of siRNA to solid tumors by super carbonate apatite (Q35571504) (← links)
- RNA interference approaches for treatment of HIV-1 infection (Q35652119) (← links)
- Multifunctional cationic lipid-based nanoparticles facilitate endosomal escape and reduction-triggered cytosolic siRNA release (Q35688089) (← links)
- Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets (Q35747814) (← links)
- Molecular mechanisms of RNA-triggered gene silencing machineries. (Q36099794) (← links)